This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Feb;163(2):56.

doi: 10.1007/s15006-021-9589-0.

Mit vier Therapiekomponenten acht Jahre Lebenszeit gewinnen

Affiliations

PMID: 33527294
DOI: 10.1007/s15006-021-9589-0

Comment

Mit vier Therapiekomponenten acht Jahre Lebenszeit gewinnen

Dirk Einecke. MMW Fortschr Med. 2021 Feb.

. 2021 Feb;163(2):56.

doi: 10.1007/s15006-021-9589-0.

Author

Affiliation

¹ Springer Medizin, München, Germany.

PMID: 33527294
DOI: 10.1007/s15006-021-9589-0

No abstract available

PubMed Disclaimer

Comment on

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.
Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Pedro Ferreira J, Zannad F, Packer M, Fonarow GC, McMurray JJV, Solomon SD. Vaduganathan M, et al. Lancet. 2020 Jul 11;396(10244):121-128. doi: 10.1016/S0140-6736(20)30748-0. Epub 2020 May 21. Lancet. 2020. PMID: 32446323 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations